Evidence map›Paper›PMID 24999379›Full record

ReviewOxidative medicine and cellular longevity2014

Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal.

Antonio Ayala, Mario F Muñoz, Sandro Argüelles

Registry-linked trialOpen access · hybridAbstract readReview
In one paragraph

Review in Oxidative medicine and cellular longevity, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05037604 (Factors Associated With Dermatoporosis), which is not on this map. Cited by 2,564 papers.

0numbers the graph read from it
0cells of the map it votes in
2,564citing papers in PubMed
88.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05037604 completednot on this mapstarted 2018, after this paper: background citation

Factors Associated With Dermatoporosis

TypeobservationalSponsorUniversidad Autonoma de San Luis PotosíRan2018 to 2019Enrolled315ConditionsSenile PurpuraArmsQuestionnaire about associated factors, Self questionnaire diagnostic tool, Physical Examination
3 · Its place in the literature

Who cites it

2,564 citing papers in PubMed, 5,954 citations in OpenAlex.

  1. Trial
  2. Article
  3. Enzymatic and non-enzymatic oxidation of fibrillar collagen.Redox report : communications in free radical research · 2026
    Review
  4. Review
  5. PROTACs in cancer therapy: targeted degradation of GPX4, PARP and epigenetic regulators.Journal of enzyme inhibition and medicinal chemistry · 2026
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. MnORSC advances · 2026
    Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. The emerging roles of disulfidptosis in cancer.Apoptosis : an international journal on programmed cell death · 2026
    Review
  20. Article

2,504 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Antonio AyalaDepartment of Biochemistry and Molecular Biology, Faculty of Pharmacy, University of Seville, Prof García Gonzales s/n., 41012 Seville, Spain.ORCID 0000-0001-9711-3711
Mario F MuñozDepartment of Biochemistry and Molecular Biology, Faculty of Pharmacy, University of Seville, Prof García Gonzales s/n., 41012 Seville, Spain.
Sandro ArgüellesDepartment of Biochemistry and Molecular Biology, Faculty of Pharmacy, University of Seville, Prof García Gonzales s/n., 41012 Seville, Spain.
Universidad de Sevilla · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lipid peroxidation can be described generally as a process under which oxidants such as free radicals attack lipids containing carbon-carbon double bond(s), especially polyunsaturated fatty acids (PUFAs). Over the last four decades, an extensive body of literature regarding lipid peroxidation has shown its important role in cell biology and human health. Since the early 1970s, the total published research articles on the topic of lipid peroxidation was 98 (1970-1974) and has been increasing at almost 135-fold, by up to 13165 in last 4 years (2010-2013). New discoveries about the involvement in cellular physiology and pathology, as well as the control of lipid peroxidation, continue to emerge every day. Given the enormity of this field, this review focuses on biochemical concepts of lipid peroxidation, production, metabolism, and signaling mechanisms of two main omega-6 fatty acids lipid peroxidation products: malondialdehyde (MDA) and, in particular, 4-hydroxy-2-nonenal (4-HNE), summarizing not only its physiological and protective function as signaling molecule stimulating gene expression and cell survival, but also its cytotoxic role inhibiting gene expression and promoting cell death. Finally, overviews of in vivo mammalian model systems used to study the lipid peroxidation process, and common pathological processes linked to MDA and 4-HNE are shown.

Indexed as

Lipid PeroxidationSignal TransductionAldehydesAnimalsHumansMalondialdehydeModels, AnimalReactive Oxygen Species4-hydroxy-2-nonenalAldehydesMalondialdehydeReactive Oxygen Species

Identifiers

PMID24999379
PMCPMC4066722
OpenAlexW2025639892

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.